MicroPort Endovascular MedTech Ltd

Price Chart

Risk-Adjusted Performance

MicroPort Endovascular MedTech Ltd (688016) Price Performance

MicroPort Endovascular MedTech Ltd (688016) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY99.62, up 0.94% from the previous close.

Over the past year, 688016 has traded between a low of CNY83.15 and a high of CNY121.45. The stock has gained 15.2% over this period. It is currently 18.0% below its 52-week high.

MicroPort Endovascular MedTech Ltd has a market capitalization of $12.22B, with a price-to-earnings ratio of 21.33 and a dividend yield of 2.29%.

About MicroPort Endovascular MedTech Ltd

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft system; Cratos and Castor, a branched aortic stent graft system; Talos, a thoracic stent graft system; and Hercules, a thoracic stent graft system with low profile delivery system. It also provides Minos, an abdominal aortic stent graft and delivery System; Aorfix, an endovascular device designed for treating abdominal aortic aneurysms; Altura, a device designed for the endovascular repair of abdominal aortic aneurysms; Aegis, a bifurcated aortic stent graft system; and L-REBOA, an aortic occlusion balloon catheter. In addition, the company offers Reewarm PTX, a drug coated balloon PTA catheter; ReeAmber, a PTA balloon dilatation catheter; Reewarm, a PTA balloon dilatation catheter; Ryflumen, a peripheral high-pressure balloon dilatation catheter; and CROWNUS, a peripheral stent system; HawkMaster, a detachable fibered embolization coils; HawkNest, a fibered embolization coils; Veryan BM3D, which is designed for the treatment of symptomatic de novo lesions in the native superficial femoral artery; Vflower, a venous stent system; SeaDragon, a PTA balloon dilatation catheter; Vewatch, a vena cava filter; Vepack, a snare retrieval kit; VeinPro, an endovenous radiofrequency closure system; Reflow-speX, a support catheter; and DEMANTOID, a peripheral vascular guide wire. Further, it provides Tipspear, a transjugular liver access set. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People's Republic of China.

Compare MicroPort Endovascular MedTech Ltd

Side-by-side comparison against top Healthcare peers.